1Neilson JR,Zheng GX,Burge CB,et al.Dynamic regula-tion of miRNA expression in ordered stages of cellulardevelopment[J].Genes Dev,2007,21(5):578-589.
2Li QJ,Chau J,Ebert PJ,et al.miR-181ais an intrinsicmodulator of T cell sensitivity and selection[J].Cell,2007,129(1):147-161.
3Lykken EA,Li QJ.microRNAs at the regulatory frontier:an investigation into how microRNAs impact the develop-ment and effector functions of CD4Tcells[J].ImmunolRes,2011,49(1/3):87-96.
4Merkerova M,Belickova M,Bruchova H.Differential ex-pression of microRNAs in hematopoietic cell lineages[J].Eur J Haematol,2008,81(4):304-310.
5Shivdasani RA.MicroRNAs:regulators of gene expres-sion and cell differentiation[J].Blood,2006,108(12):3646-3653.
5Roggli E, Britan A, Gattesco S, et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells[J]. Diabetes, 2010,59:978-986.
6Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection[J]. Cell, 2007,129:147-161.
7Neilson JR, Zheng GX, Burge CB, et al. Dynamic regulation of miRNA expression in ordered stages of cellular development[J]. Genes Dev, 2007,21:578-589.
8Zhou X, Jeker LT, Fife BT, et al. Selective miRNA disruption in Treg cells leads to uncontrolled autoimmunity[J].J Exp Med, 2008,205:1983-1991.
9Nielsen LB, Wang C, Srensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diaetes and healthy controls: evidence that mir-25 associates to residual beta-cell function and glycaemic control during disease progression[J]. Exp Diabetes Res, 2012,2012:896362.
10Chen WB, Gao L, Matthew W, et al.Deletion of miRNAs in bone marrow prevents streptozotocin-induced murine autoimmune diabetes but deletion of miR-155 does not[J]. Cell Cycle, 2013,12:1151-1152.
